20-33224402-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BS1BS2
The NM_178466.5(BPIFA3):c.326C>A(p.Ser109*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0011 in 1,614,172 control chromosomes in the GnomAD database, including 16 homozygotes. Variant has been reported in ClinVar as Benign (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.0057 ( 8 hom., cov: 32)
Exomes 𝑓: 0.00062 ( 8 hom. )
Consequence
BPIFA3
NM_178466.5 stop_gained
NM_178466.5 stop_gained
Scores
1
3
3
Clinical Significance
Conservation
PhyloP100: 0.883
Genes affected
BPIFA3 (HGNC:16204): (BPI fold containing family A member 3) Predicted to enable lipid binding activity. Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP6
Variant 20-33224402-C-A is Benign according to our data. Variant chr20-33224402-C-A is described in ClinVar as [Benign]. Clinvar id is 3045464.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0057 (869/152326) while in subpopulation AFR AF= 0.0197 (818/41572). AF 95% confidence interval is 0.0186. There are 8 homozygotes in gnomad4. There are 429 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 8 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BPIFA3 | NM_178466.5 | c.326C>A | p.Ser109* | stop_gained | 3/7 | ENST00000375454.8 | NP_848561.2 | |
BPIFA3 | NM_001042439.2 | c.278+441C>A | intron_variant | NP_001035904.1 | ||||
BPIFA3 | XR_244132.4 | n.553C>A | non_coding_transcript_exon_variant | 3/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BPIFA3 | ENST00000375454.8 | c.326C>A | p.Ser109* | stop_gained | 3/7 | 5 | NM_178466.5 | ENSP00000364603.3 | ||
BPIFA3 | ENST00000375452.3 | c.278+441C>A | intron_variant | 1 | ENSP00000364601.3 | |||||
BPIFA3 | ENST00000490499.5 | n.705C>A | non_coding_transcript_exon_variant | 4/7 | 1 | |||||
BPIFA3 | ENST00000471233.1 | n.536C>A | non_coding_transcript_exon_variant | 3/7 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00564 AC: 859AN: 152208Hom.: 8 Cov.: 32
GnomAD3 genomes
AF:
AC:
859
AN:
152208
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00150 AC: 378AN: 251236Hom.: 5 AF XY: 0.00119 AC XY: 162AN XY: 135750
GnomAD3 exomes
AF:
AC:
378
AN:
251236
Hom.:
AF XY:
AC XY:
162
AN XY:
135750
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000623 AC: 911AN: 1461846Hom.: 8 Cov.: 31 AF XY: 0.000549 AC XY: 399AN XY: 727218
GnomAD4 exome
AF:
AC:
911
AN:
1461846
Hom.:
Cov.:
31
AF XY:
AC XY:
399
AN XY:
727218
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00570 AC: 869AN: 152326Hom.: 8 Cov.: 32 AF XY: 0.00576 AC XY: 429AN XY: 74486
GnomAD4 genome
AF:
AC:
869
AN:
152326
Hom.:
Cov.:
32
AF XY:
AC XY:
429
AN XY:
74486
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
76
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
218
Asia WGS
AF:
AC:
7
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
BPIFA3-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 28, 2021 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Benign
D
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at